Clostridium difficile infection

There are 9 papers on clostridium difficile infection in aging research: 1 trial and 6 observational studies in people, 2 reviews.

Disease

9 papers study it15 more mention it7 findings

See all 24 papers on clostridium difficile infection

“1-year mortality rates (48.2% vs 31.1%, P < 0.001) were significantly higher among the CDI residents vs non-CDI residents.”
Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort studyBMC geriatrics2016doi:10.1186/s12877-016-0367-2
  • Human trial1
  • Humans6

Interventions

1

Fecal microbiota transplantation

downin humans1

1 study
  1. Fecal microbiota transplantation protects against clostridium difficile infection in humans.

    “The innovation in GM dysbiosis is intervention by Fecal Microbiota Transplantation (FMT), which has been confirmed as a therapy for recurrent Clostridium difficile infections”

    Review

    Dysbiosis and fecal microbiota transplant: Contemplating progress in health, neurodegeneration and longevity

    Biogerontology

More on Fecal microbiota transplantation

Upstream

1

C. difficile toxin-specific antibody

downin humans1

1 study
  1. C. difficile toxin-specific antibody protects against clostridium difficile infection in humans.

    “C. difficile toxin-specific antibody response protects the host against initial and recurrent infections”

    Review

    Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on C. difficile toxin-specific antibody

Associations

4

Mortality

upin humans2

2 studies
  1. Clostridium difficile infection is associated with mortality in humans (US nursing home residents; propensity score matched comparison) (1-year mortality: 48.2% vs 31.1%; P < 0.001).

    “1-year mortality rates (48.2% vs 31.1%, P < 0.001) were significantly higher among the CDI residents vs non-CDI residents.”

    HumansUS nursing home residents; propensity score matched comparison30 days to 1 year

    Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study

    BMC geriatrics

  2. Clostridium difficile infection is associated with mortality in humans (propensity-adjusted comparison of CDI and non-CDI Medicare patients) (42.6% vs 23.4%).

    “CDI was associated with near doubling of both mortality (42.6% vs 23.4%, P<.001) and total healthcare costs”

    Humanspropensity-adjusted comparison of CDI and non-CDI Medicare patients12 months

    Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States

    Infection control and hospital epidemiology

Total health care costs

upin humans1

1 study
  1. Clostridium difficile infection is associated with total health care costs in humans (US nursing home residents; propensity score matched comparison) ($28,621 vs $13,644; P < 0.001).

    “Total health care costs within 2 months following the first CDI episode were also significantly higher for CDI residents ($28,621 vs $13,644, P < 0.001).”

    HumansUS nursing home residents; propensity score matched comparison2 months following the first CDI episode

    Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study

    BMC geriatrics

Total healthcare costs

upin humans1

1 study
  1. Clostridium difficile infection is associated with total healthcare costs in humans (propensity-adjusted comparison of CDI and non-CDI Medicare patients) ($64,807±$66,480 vs $38,128±$46,485).

    “CDI was associated with near doubling of both mortality (42.6% vs 23.4%, P<.001) and total healthcare costs ($64,807±$66,480 vs $38,128±$46,485, P<.001).”

    Humanspropensity-adjusted comparison of CDI and non-CDI Medicare patients12 months

    Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States

    Infection control and hospital epidemiology

Antibiotic therapy

upin humans1

1 study
  1. Antibiotic therapy is associated with clostridium difficile infection in humans.

    “The impact of antibiotic therapy on the increased incidence of CDI was clearly confirmed in our study group when examining patients' histories.”

    HumansHospitalized patients with confirmed CDI; antibiotic exposure assessed from patient historiesn = 235

    Can we improve the therapy of Clostridium difficile infection in elderly patients?

    Wiener klinische Wochenschrift

More on Antibiotic therapy

Trial sponsors

Funding

1 grant since 2019

National Institute on Aging$640K

Latest

See all 24 papers on clostridium difficile infection